| Authors: |
Adeleke S; School of Biomedical Engineering and Imaging Sciences (BMEIS), King's College London, London, UK. olusola.adeleke@kcl.ac.uk., Galante JR; Royal Marsden Hospital NHS Foundation Trust, London, UK., Wang Y; Royal Free London NHS Foundation Trust, London, UK., Azad G; Guy's & St Thomas' NHS Foundation Trust, London, UK., Wan S; Institute of Nuclear Medicine, University College London, London, UK., Haroon A; St Bartholomew's Hospital NHS Foundation Trust, London, UK., Bianchini D; Kent Oncology Centre, Maidstone & Tunbridge Wells Hospitals, Kent, UK., Bomanji J; Institute of Nuclear Medicine, University College London, London, UK., Hofman MS; Prostate Cancer Theranostics and Imaging Centre of Excellence (ProsTIC), Molecular Imaging and Therapeutic Nuclear Medicine, Cancer Imaging, Peter MacCallum Centre Melbourne, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia., Young TS; California Institute for Biomedical Research (CALIBR), Scripps Research, La Jolla, CA, USA., Cook GJR; School of Biomedical Engineering and Imaging Sciences (BMEIS), King's College London, London, UK. |
